Vireo Health International, Inc. Share Price OTC Markets
Equities
VREOF
CA92767A1075
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.416 USD | +0.24% | -4.59% | +73.33% |
05-07 | Transcript : Goodness Growth Holdings, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Goodness Growth Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 96.49M 7.6B | Sales 2025 * | - | Capitalization | 99.94M 7.87B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.04 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 64.58% |
Latest transcript on Vireo Health International, Inc.
1 day | +0.24% |
Managers | Title | Age | Since |
---|---|---|---|
Kyle Kingsley
FOU | Founder | 49 | 22/11/04 |
Joshua Rosen
CEO | Chief Executive Officer | 51 | 11/08/21 |
Amber Shimpa
PSD | President | 45 | 31/12/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joshua Rosen
CEO | Chief Executive Officer | 51 | 11/08/21 |
Kyle Kingsley
FOU | Founder | 49 | 22/11/04 |
Amber Shimpa
PSD | President | 45 | 31/12/14 |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.29% | 4.15B | |
+144.23% | 2.3B |
- Stock Market
- Equities
- GDNS Stock
- VREOF Stock